Nir Barzilai
InvestorAdvisory Board at LongeVC
About
Nir Barzilai is Director of the Institute for Aging Research and a Professor in the Departments of Medicine and Genetics at the Albert Einstein College of Medicine, and serves as Principal Investigator at the Nathan Shock and Glenn centers. He leads the EXCEL Study, which aims to recruit centenarians and their families to identify longevity genes, and the TAME study, which tests whether aging-related conditions can be delayed in humans using metformin. He has authored over 290 peer-reviewed papers, received the NIH Merit Award, the Irving S. Wright Award (2010), and the IPSEN Longevity Award (2018), and wrote the book "Age Later" (2020).
Contact· self-published, not guessed
Invests in
Longevity
Colleagues at LongeVC
Alex Zhavoronkov
Venture Partner at LongeVC
Artem Trotsyuk
Operating Partner - US at LongeVC
Artemy Shumskiy
Principal at LongeVC
Christine Yuan Huang
Advisory Board at LongeVC
Dr. Weigao Wang
Venture Fellow at LongeVC
Evelyne Bischof
Venture Partner at LongeVC
Evgeny Izumchenko
Venture Partner at LongeVC
Garri Zmudze
Managing Partner at LongeVC
Frequently asked questions
- Who is Nir Barzilai?
- Nir Barzilai is Director of the Institute for Aging Research and a Professor in the Departments of Medicine and Genetics at the Albert Einstein College of Medicine, and serves as Principal Investigator at the Nathan Shock and Glenn centers. He leads the EXCEL Study, which aims to recruit centenarians and their families to identify longevity genes, and the TAME study, which tests whether aging-related conditions can be delayed in humans using metformin. He has authored over 290 peer-reviewed papers, received the NIH Merit Award, the Irving S. Wright Award (2010), and the IPSEN Longevity Award (2018), and wrote the book "Age Later" (2020).
- Where does Nir Barzilai work?
- Nir Barzilai is Advisory Board at LongeVC.
- What does Nir Barzilai invest in?
- Nir Barzilai invests in Longevity.